Industry reports
Editor highlights

Pharmaceutical Industry in Canada: Market Research Reports, Statistics and Analysis

You might be interested in: drug, clinical trial, medicine, more »

» View Public Reports

About 1 500 reports

Pharmaceutical Sector in Canada

  • Industry report
  • March 2014
  • 31 pages

... T as ia & pac ific n. A frica & m iddl e ea st sub -sah aran afr ica e.Eu rop e & c. A sia w. E uro pe & u.S . The percent of people aged 40+ with no previous diagnosis of diabetes ...

Pharmaceutical Sector in The United States and Canada

  • Industry report
  • January 2014
  • 11 pages
  • by Research Paper

Pharmaceutical Sector Analysis in Canada

  • Industry report
  • September 2013
  • 51 pages
  • by Research Paper

... Perceived mental health good self-perceived general health p e r c e nt 6 5 - 7 4 7 5 - 8 4 85+ percentage of people in good health, by age group, household population, aged 65 and over (shields and martel, 2006 ...

The Canadian Pharmaceutical Business Analysis

  • Industry report
  • September 2013
  • 51 pages

The Canadian Pharmaceutical Industry : Innovation and Technology Trends

  • Industry report
  • June 2013
  • 29 pages

... apneadx ) Apneadx Is a portable, cordless battery operated device to diagnose sleep apnea in the comfort of someone S home description Software identifies and score apneas from breath sound ...

Pharmaceutical Business Analysis in Canada and China

  • Industry report
  • April 2013
  • 67 pages

... Med 2006;38:52-63 these features lead to type 2 diabetes and cardiovascular disease visceral obesity is associated with a cluster of metabolic abnormalities often described as the Metabolic syndrome ...

Pharmaceutical Market in Canada, Brazil and The United States

  • Industry report
  • December 2012
  • 43 pages

... Patients with other demential syndromes such as vascular dementia, temporal frontal dementia, lewy bodies, or any other clinical frame that would suggest non-alzheimer's dementia were excluded from ...

The Canadian Pharmaceutical Industry

  • Industry report
  • November 2012
  • 39 pages

... Or a sulfonylurea to improve glycemic control in patients with type 2 diabetes mellitus, when maximally tolerated doses of these oral therapies in addition to diet and exercise do not provide adequate glycemic ...

Pharmaceutical Market in Canada

  • Industry report
  • November 2012
  • 39 pages

... Heart problems 3X back pain 2-3X conflict 2-3X mental health problems 2-3X infections 2-3X injuries 2X substance abuse martin ...


» Purchase Premium Reports (From $ 125 - $ 4 995)

About 600 reports
PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

Pharmapoint: Prophylactic Hepatitis B Virus Vaccines - ...

January 2014 $ 4 995

Prochymal (crohn's Disease) - Forecast And Market Analy ...

January 2014 $ 3 495

Stelara (crohn's Disease) - Forecast And Market Analysi ...

January 2014 $ 3 495

Tysabri (crohn's Disease) - Forecast And Market Analysi ...

January 2014 $ 3 495

Vercirnon (crohn's Disease) - Forecast And Market Analy ...

January 2014 $ 3 495

Engerix-b (prophylactic Hepatitis B Virus Vaccines) - F ...

January 2014 $ 3 495

Ambirix (prophylactic Hepatitis B Virus Vaccines) - For ...

January 2014 $ 3 495

Fendrix (prophylactic Hepatitis B Virus Vaccines) - For ...

January 2014 $ 3 495

Heplisav (prophylactic Hepatitis B Virus Vaccines) - Fo ...

January 2014 $ 3 495

» Read our Company Profiles

4 Companies

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.